NEW YORK (GenomeWeb) – Royal Philips today announced an expanded partnership between its Healthcare Research arm and New York Medical College (NYMC) which will focus on personalized cancer care.
Previously, NYMC has collaborated with Philips' genomics arm to develop IntelliSpace Genomics, an application built on Philips Healthsuite that offers analysis workflows for pathologists, oncologists, and researchers. The tool combines and integrates data from multiple sources including raw sequence, clinical data, longitudinal patient records, medical images, pathology data, and more.
Under the terms of the expanded partnership, scientists from Philips IntelliSpace Genomics will be located at the NYMC and share space with [email protected], the NYMC's biotechnology incubator in Valhalla, NY. The partners plan to work on computational genomics projects that will support Philips' work in personalized cancer care and result in the development of innovative solutions that can address pressing healthcare challenges, the company said.
Working from space on the NYMC campus will also enable Philips' researchers to collaborate more closely with partners at three affiliated teaching hospitals on Westchester Medical Center Health Network's (WMCHealth) campus in Valhalla, the company said.
Recently, WMCHealth launched a new precision medicine initiative that will use the IntelliSpace solution to combine genomic and clinical data to offer more tailored treatments for patients. Philips is also expanding the annotation and interpretation capabilities of the IntelliSpace platform via a partnership with clinical interpretation services provider N-of-One.